Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
TAG Oil prepares for flow testing of its first unconventional oil well in Egypt (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

SQI Diagnostics Inc V.SQD


Primary Symbol: V.SQD.H Alternate Symbol(s):  SQIDF

Healthcare Medical Devices
SQI Diagnostics Inc. is a Canada-based company that is focused on lung health. The Company is engaged in the development and manufacturing of respiratory health and precision medicine tests that run on its fully automated systems. Its clinical solutions include Rapid Acute Lung Injury Diagnostic (RALI-Dx), lung transplant diagnostics, COVID-19 testing and surveillance testing solutions. Its RALI-Dx IL-6 Severity Triage Test and the RALI-fast IL-6 Severity Triage point of care (POC) Test each help clinicians identify which patients with SARS-CoV-2 are predicted to have a severe inflammatory response and should or should not be admitted to the hospital. Its RALI-Dx delivers results from the lab in less than an hour while RALI-fast delivers results at the patient point-of-care in about 15 minutes. The Company’s TORdx LUNG Test measures inflammation at the molecular level to assess the health of the donor lung. The Company is also focused on its organ transplant pipeline of products.


TSXV:SQD.H - Post by User

SQI Diagnostics Inc
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(494)
•••
Post by FactFinder1994on May 26, 2023 3:26pm
87 Views
Post# 35466332

(LBE) & (CLES) Centralized Lung Evaluation System

(LBE) & (CLES) Centralized Lung Evaluation System Lung Bioengineering (LBE) 

EVLP Specialist candidates must have significant clinical experience in donation/transplantation. All EVLP Specialists undergo intensive EVLP training to build on their clinical foundation. This includes completing a rotation in Toronto General Hospital’s Thoracic Surgery Program.

Centralized Lung Evaluation System (CLES)

LBE has invested much capital over the better part of last decade and has the infrastructure already in place, including established partnerships with many of the top transplant facilities in the USA.  UHN is an integrated partner with both LBE & SQI, and each play an important role in the evolution of the transplant ecosystem.  Win-Win-Win describes the relationship for all.  TORdx provides more information in a timely manner with which to act on.  When lives are at stake, it is important to have all of the best resources available.  

UHN + LBE + SQI = WIN-WIN-WIN      

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities